WRF
AXNX

Waddell & Reed Financial’s Axonics, Inc. Common Stock AXNX Stock Holding History

Waddell & Reed Financial’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$65.4M Sell
1,092,075
-117,690
-10% -$6.4M 0.13% 192
2020
Q4 		$60.4M Buy
1,209,765
+139,538
+13% +$6.55M 0.13% 190
2020
Q3 		$54.6M Buy
1,070,227
+961,771
+887% +$40.1M 0.13% 186
2020
Q2 		$3.81M Buy
+108,456
New +$3.74M 0.01% 430

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Waddell & Reed Financial's AXNX Position: Q1 2021 in Review

Waddell & Reed Financial reduced its Axonics, Inc. Common Stock (AXNX) stake by 9.7% in Q1 2021, selling an estimated $6.4M and leaving 1,092,075 shares worth $65.4M. The position accounts for 0.13% of the portfolio, ranked #192.

Waddell & Reed Financial first reported a position in AXNX in Q2 2020 and has held it in 4 quarters since. 160 funds tracked by Wall St. Rank hold AXNX as of Q1 2021.

  • Waddell & Reed Financial held 1,092,075 shares of Axonics, Inc. Common Stock worth $65.4M as of Q1 2021.
  • Waddell & Reed Financial sold 117,690 Axonics, Inc. Common Stock shares in Q1 2021, an estimated $6.4M.
  • Axonics, Inc. Common Stock made up 0.13% of Waddell & Reed Financial's portfolio in Q1 2021, its #192 holding.
  • Waddell & Reed Financial first reported a position in Axonics, Inc. Common Stock in Q2 2020 and has held it in 4 quarters since.
  • 160 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2021.

Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.